Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin P Alyea

Showing results (51-60 of 176) with videos related to

Pageof 18
Sort By:
Haematologica|March 26, 2017
Venous thromboembolism is associated with graft-<i>versus</i>-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantationNatasha Kekre, Haesook T Kim, Vincent T Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 13, 2011
The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantationKarim E Abou-Nassar, Haesook T Kim, Jeff Blossom, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2010
Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndromeJohn Koreth, Melinda Biernacki, Julie Aldridge, et al.
Blood|May 6, 2003
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantationJoseph H Antin, Haesook T Kim, Corey Cutler, et al.
Leukemia & Lymphoma|March 5, 2003
Quantitative monitoring of BCR/ABL transcript during STI-571 therapyCatherine J Wu, Donna Neuberg, Antoinette Chillemi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantationPhilippe Armand, Haesook T Kim, Daniel J DeAngelo, et al.
Blood|August 29, 2009
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donorsJohn Koreth, Kristen E Stevenson, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2011
Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantationVincent T Ho, Haesook T Kim, Julie Aldridge, et al.
American Journal of Hematology|August 19, 2014
Sequential infusion of donor-derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantationVincent T Ho, Haesook T Kim, Grace Kao, et al.
Transfusion|February 14, 2004
Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapyAbba C Zubair, David Zahrieh, Heather Daley, et al.
Pageof 18

Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
Haematologica|March 26, 2017
Venous thromboembolism is associated with graft-<i>versus</i>-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantationNatasha Kekre, Haesook T Kim, Vincent T Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 13, 2011
The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantationKarim E Abou-Nassar, Haesook T Kim, Jeff Blossom, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2010
Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndromeJohn Koreth, Melinda Biernacki, Julie Aldridge, et al.
Blood|May 6, 2003
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantationJoseph H Antin, Haesook T Kim, Corey Cutler, et al.
Leukemia & Lymphoma|March 5, 2003
Quantitative monitoring of BCR/ABL transcript during STI-571 therapyCatherine J Wu, Donna Neuberg, Antoinette Chillemi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantationPhilippe Armand, Haesook T Kim, Daniel J DeAngelo, et al.
Blood|August 29, 2009
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donorsJohn Koreth, Kristen E Stevenson, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2011
Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantationVincent T Ho, Haesook T Kim, Julie Aldridge, et al.
American Journal of Hematology|August 19, 2014
Sequential infusion of donor-derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantationVincent T Ho, Haesook T Kim, Grace Kao, et al.
Transfusion|February 14, 2004
Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapyAbba C Zubair, David Zahrieh, Heather Daley, et al.
Pageof 18